CFM
BIOA

Cornerstone Financial Management’s BioAge Labs BIOA Stock Holding History

Cornerstone Financial Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.92K Hold
110
– – ﹤0.01% 751
2025
Q4 		$1.46K Buy
+110
New +$975 ﹤0.01% 793

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Cornerstone Financial Management's BIOA Position: Q1 2026 in Review

Cornerstone Financial Management held its BioAge Labs (BIOA) position steady in Q1 2026 at 110 shares worth $1.92K. The position accounts for ﹤0.01% of the portfolio, ranked #751.

Cornerstone Financial Management first reported a position in BIOA in Q4 2025 and has held it in 2 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Cornerstone Financial Management held 110 shares of BioAge Labs worth $1.92K as of Q1 2026.
  • Cornerstone Financial Management left its BioAge Labs share count unchanged in Q1 2026.
  • BioAge Labs made up ﹤0.01% of Cornerstone Financial Management's portfolio in Q1 2026, its #751 holding.
  • Cornerstone Financial Management first reported a position in BioAge Labs in Q4 2025 and has held it in 2 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Cornerstone Financial Management's 13F filing for Q1 2026, filed 8 May 2026.